43 results on '"Kronenberger, Bernd"'
Search Results
2. Vesicle-associated microRNAs are released from blood cells on incubation of blood samples
3. Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma
4. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma
5. High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma
6. Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis
7. Reduced Efficacy of the Plk1 Inhibitor BI 2536 on the Progression of Hepatocellular Carcinoma due to Low Intratumoral Drug Levels
8. Nucleos(t)ide analogue treatment reduces apoptotic activity in patients with chronic hepatitis B
9. Influence of amantadine on CD81 expression on lymphocytes in chronic hepatitis C
10. Meta-analysis Shows Extended Therapy Improves Response of Patients With Chronic Hepatitis C Virus Genotype 1 Infection
11. Development and Evaluation of a FACS-Based Medium-Throughput Assay for HCV Entry Inhibitors
12. Current and future treatment options for HCV
13. Future treatment options for HCV: Double, triple, what is the optimal combination?
14. Novel Hepatitis C Drugs in Current Trials
15. Mutagenic Effect of Ribavirin on Hepatitis C Nonstructural 5B Quasispecies In Vitro and During Antiviral Therapy
16. Association of serum interleukin-8 with virologic response to antiviral therapy in patients with chronic hepatitis C
17. Cholecystokinin Stimulates Extracellular Signal-regulated Kinase through Activation of the Epidermal Growth Factor Receptor, Yes, and Protein Kinase C: SIGNAL AMPLIFICATION AT THE LEVEL OF Raf BY ACTIVATION OF PROTEIN KINASE Cε
18. Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: A placebo-controlled trial
19. Protein kinase A mediates cAMP-induced tyrosine phosphorylation of the epidermal growth factor receptor
20. Cyclic AMP Induces Transactivation of the Receptors for Epidermal Growth Factor and Nerve Growth Factor, Thereby Modulating Activation of MAP Kinase, Akt, and Neurite Outgrowth in PC12 Cells
21. Interferon alfa down-regulates CD81 in patients with chronic hepatitis C
22. Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels
23. Correction: Cyclic AMP induces transactivation of the receptors for epidermal growth factor and nerve growth factor, thereby modulating activation of MAP kinase, Akt, and neurite outgrowth in PC12 cells.
24. Pretreatment serum microRNA-122 is not predictive for treatment response in chronic hepatitis C virus infection
25. Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura
26. 1058 Multiple Plastic Stents (MPS) vs. Covered Self-Expandable Metal Stents (cSEMS) for Endoscopic Therapy in Stenosis of the Choledocho-Choledochal Anastomosis After Orthotopic Liver Transplantation: Data From a Randomised Multicentre Trial
27. Su1584 Direct Retrograde Cholangioscopy With a New Prototype Cholangioscope in Comparison to an Ultraslim Standard Endoscope
28. Su1608 No Distal Migration in Unfixed vs. Fixed Cell Structure Covered Self-Expanding Metal Stents for Treatment of Benign Biliary Disease
29. T2005 Dynamics of Apoptotic Activity in Patients With Chronic Hepatitis C Treated With Albinterferon Alfa-2B or Peginterferon Alfa-2a
30. Occludin a New HCV Entry Factor: Is the List of Essential Hepatitis C Virus Receptors Complete?
31. Highly sensitive hepatitis C virus RNA detection assays for decision of treatment (dis)continuation in patients with chronic hepatitis C
32. Reply
33. Association of HCV-related mixed cryoglobulinemia with specific mutational pattern of the HCV E2 protein and CD81 expression on peripheral B lymphocytes
34. 1006 Viral kinetics in chronically HCV infected patients with persistently normal or elevated ALT levels
35. 606 Impaired quality of life in patients with chronic hepatitis C and persistently normal aminotransferase levels
36. Mutations within the CD81-binding sites and hypervariable region (HVR) 2 of the envelope (E) 2 protein and correlation with treatment response in HCV infected patients
37. Triple therapy with amantadine sulphate plus ribavirin and interferon-alpha in previously untreated patients with chronic hepatitis C: results of a double-blind, placebo-controlled trial
38. Lack of birth defects after paternal exposure to lamivudine
39. Influence of interferon-alpha on CD81-expression in HCV-positive patients
40. Dynamics of hepatitis C virus quasispecies turnover during interferon-a treatment
41. Mutations within the E2 and NS5A protein in patients infected with hepatitis C virus type 3A and correlation with treatment response
42. Dedifferentiation of human hepatocytes by extracellular matrix proteins in vitro: quantitative and qualitative investigation of cytokeratin 7, 8, 18, 19 and vimentin filaments
43. Development of an ultrasensitive in vitro assay to monitor growth of primary cell cultures with reduced mitotic activity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.